| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,619 |
2,152 |
$125K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,287 |
1,160 |
$98K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
385 |
174 |
$29K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
368 |
313 |
$27K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
313 |
270 |
$24K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
265 |
214 |
$22K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
951 |
877 |
$18K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
103 |
100 |
$14K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
290 |
225 |
$13K |
| 96127 |
|
444 |
361 |
$7K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
97 |
86 |
$7K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
52 |
45 |
$4K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
113 |
109 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
41 |
41 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
43 |
35 |
$671.31 |
| 87081 |
|
36 |
29 |
$627.84 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
12 |
12 |
$615.72 |
| 99174 |
|
17 |
13 |
$304.95 |
| 85018 |
|
52 |
47 |
$118.32 |
| 36416 |
|
28 |
25 |
$82.00 |
| 1036F |
|
80 |
55 |
$0.00 |
| 1220F |
|
80 |
55 |
$0.00 |
| 1003F |
|
386 |
273 |
$0.00 |
| 99072 |
|
191 |
166 |
$0.00 |